hs-cTnI reagent (chemiluminescence assay)

Hs-cTnl                                                                                           

Gold standard of the AMI diagnosis

Ultra sensitivecTnltesting, earlier and more sensitive for AMI diagnosis

Recommended to purchase after comparing with Siemens ADVIA Centaur TnI-Ultra

Clinical significance                                                                  

Diagnose AMI

Estimate infarct size and risk stratification, prognosis evaluation of AMI patients. Assist 

to diagnose heart failure, evaluate heart functional status of patients

Advantage                                                                                      

High sensitivity:0.02ng/ml , real ultra sensitive cTnItest.

High accuracy:99% correlation with SiemensADVIA Centaur TnI-Ultra

Result correlation analysis between NormancTnI and ADVIA Centaur TnI-Ultra

Comparison between hs-cTnI and cTnl

Clinical significanceTest requirement

Content ,hs-ctnilctnl

earlist result time 1 to 3 hrsafter chest pain3 to 8 hrsafter chest pain

minimal myocardial injurysensitive insensitive

misdiagnosis rate  low                                   high

sensitivity requirement  0.02ng/ml                             0.05ng/ml

methodology     high sensitivity (chemiluminescence)     common (colloidal gold, 

fluorescence, turbidity

CV (99 percentile)<10%>10%

Relation between treatment time and death rate 

Time           death rate

after AMI, treated within 1 hr             about 1%

after AMI, treated within 6 hrs           about 10%-12%

every 30 mins delay                              increase 1%

Agent Wanted                                                                              

If you are interested in working with us, please feel free to contact.